Published in Spine (Phila Pa 1976) on August 01, 2002
Clinical and radiological outcome of anterior-posterior fusion versus transforaminal lumbar interbody fusion for symptomatic disc degeneration: a retrospective comparative study of 133 patients. Eur Spine J (2009) 1.29
Current strategies for the restoration of adequate lordosis during lumbar fusion. World J Orthop (2015) 0.93
Diagnosis and surgical treatment of back pain originating from endplate. Eur Spine J (2009) 0.90
Anterior interbody arthrodesis with percutaneous posterior pedicle fixation for degenerative conditions of the lumbar spine. Eur Spine J (2011) 0.87
Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Eur Spine J (2006) 0.85
The LP-ESP(®) lumbar disc prosthesis with 6 degrees of freedom: development and 7 years of clinical experience. Eur J Orthop Surg Traumatol (2013) 0.84
Biomechanical study of lumbar spinal arthroplasty with a semi-constrained artificial disc (activ L) in the human cadaveric spine. J Korean Neurosurg Soc (2009) 0.83
Dynamics of an intervertebral disc prosthesis in human cadaveric spines. HSS J (2007) 0.79
One-stage combined lumbo-sacral fusion, by anterior then posterior approach: clinical and radiological results. Eur Spine J (2013) 0.76
Pedicle-Screw-Based Dynamic Systems and Degenerative Lumbar Diseases: Biomechanical and Clinical Experiences of Dynamic Fusion with Isobar TTL. ISRN Orthop (2013) 0.75
Clinical outcomes of single-level lumbar artificial disc replacement compared with transforaminal lumbar interbody fusion in an Asian population. Singapore Med J (2015) 0.75
Operative Management of Lumbar Degenerative Disc Disease. Asian Spine J (2016) 0.75
Experimental and clinical analysis of a posterolateral lumbar appendicular bone graft fusion. Int J Clin Exp Med (2015) 0.75
Predictors of Long Term Opioid Use following Lumbar Fusion Surgery. Spine (Phila Pa 1976) (2017) 0.75
Food insufficiency is associated with high-risk sexual behavior among women in Botswana and Swaziland. PLoS Med (2007) 4.48
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer (2004) 3.03
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res (2009) 1.98
Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev (2012) 1.84
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res (2012) 1.78
Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications. J Am Diet Assoc (2005) 1.76
Exploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa. AIDS Patient Care STDS (2010) 1.73
Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov (2012) 1.63
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer (2012) 1.60
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle (2012) 1.54
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer (2011) 1.46
Removal of lumbar instrumentation for the treatment of recurrent low back pain in the absence of pseudarthrosis. Arch Orthop Trauma Surg (2003) 1.33
The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol Endocrinol (2008) 1.32
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation. Mol Cancer Ther (2007) 1.32
Interventions to improve adherence to antiretroviral therapy in children with HIV infection. Cochrane Database Syst Rev (2011) 1.31
Changes in dietary intake after diagnosis of breast cancer. J Am Diet Assoc (2004) 1.30
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev (2011) 1.22
Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. Cancer Res (2007) 1.20
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer. FASEB J (2007) 1.19
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer (2010) 1.18
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiol Biomarkers Prev (2010) 1.05
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer Res (2005) 1.02
Circulating microRNAs: macro-utility as markers of prostate cancer? Endocr Relat Cancer (2012) 1.02
Ex vivo culture of human prostate tissue and drug development. Nat Rev Urol (2013) 1.00
Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. Clin Cancer Res (2003) 0.99
HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr (2004) 0.97
Disease profile of children under 5 years attending primary health care clinics in a high HIV prevalence setting in South Africa. Trop Med Int Health (2010) 0.97
HIV-infected adolescent mothers and their infants: low coverage of HIV services and high risk of HIV transmission in KwaZulu-Natal, South Africa. PLoS One (2013) 0.94
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. J Steroid Biochem Mol Biol (2008) 0.93
Hsp90: still a viable target in prostate cancer. Biochim Biophys Acta (2012) 0.92
Shamba Maisha: randomized controlled trial of an agricultural and finance intervention to improve HIV health outcomes. AIDS (2015) 0.91
GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor. Biol Chem (2005) 0.90
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells. PLoS One (2011) 0.89
Traditional healers for HIV/AIDS prevention and family planning, Kiboga District, Uganda: evaluation of a program to improve practices. AIDS Behav (2005) 0.89
Perioperative complications in revision anterior lumbar spine surgery: incidence and risk factors. Spine (Phila Pa 1976) (2009) 0.88
Molecular pathology and prostate cancer therapeutics: from biology to bedside. J Pathol (2014) 0.88
Dual and triple therapy to prevent mother-to-child transmission of HIV in a resource-limited setting - lessons from a South African programme. S Afr Med J (2011) 0.88
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors. Oncotarget (2013) 0.88
SGTA: a new player in the molecular co-chaperone game. Horm Cancer (2013) 0.86
Functional outcome analysis including preoperative and postoperative SF-36 for surgically treated adult isthmic spondylolisthesis. Spine (Phila Pa 1976) (2003) 0.86
Double disclosure bind: complexities of communicating an HIV diagnosis in the context of unintended pregnancy in Durban, South Africa. AIDS Behav (2014) 0.86
Challenges faced by health-care providers offering infant-feeding counseling to HIV-positive women in sub-Saharan Africa: a review of current research. AIDS Care (2014) 0.85
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocr Relat Cancer (2012) 0.84
The dynamic and static modification of the epigenome by hormones: a role in the developmental origin of hormone related cancers. Biochim Biophys Acta (2009) 0.84
Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription. BMC Biochem (2013) 0.83
Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Mol Cell Endocrinol (2011) 0.83
Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptor. Mol Cell Endocrinol (2007) 0.82
Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client. J Mol Endocrinol (2012) 0.82
Functional and radiological outcomes of 360 degrees fusion of three or more motion levels in the lumbar spine for degenerative disc disease. Spine (Phila Pa 1976) (2009) 0.81
Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells. Mol Cell Endocrinol (2011) 0.81
Radiculopathy in degenerative lumbar scoliosis: correlation of stenosis with relief from selective nerve root steroid injections. Pain Med (2010) 0.80
Disc space injection with marcaine as a method to evaluate painful nonunion of an interbody fusion device: a case report. Spine J (2006) 0.80
Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli. Am J Pathol (2012) 0.80
Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation. Int J Cancer (2013) 0.79
Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers. Prostate (2012) 0.79
Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers. Prostate (2014) 0.78
Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease. Methods Mol Biol (2013) 0.78
Finding the place of histone deacetylase inhibitors in prostate cancer therapy. Expert Rev Clin Pharmacol (2009) 0.77
Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo. Menopause (2014) 0.76
Revision lumbar arthrodesis for the treatment of lumbar cage pseudoarthrosis: complications. J Spinal Disord Tech (2008) 0.75